ENGOT-EN20/GOG-3083/XPORT-EC-042 Xport-EC-042 - A Phase 3, Randomized, placebo-controlled, double-blind, Multicenter trial of Selinexor in maintenance therapy after systemic therapy for patients with P53wild-type, advanced or recurrent endometrial carcinoma

Project: Research

Project Details

Project Description

NMA HREC Reference Number: 101120
NMA SSA Reference Number: SSA/101120/MonH-2023-397596(v1)
Monash Health Local Reference: RES-23-0000-562A

StatusActive
Effective start/end date30/10/23 → 29/10/28